Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2014

Open Access 01-12-2014 | Research article

Prevalence of depression among people with type 2 diabetes mellitus: a cross sectional study in Palestine

Authors: Waleed M Sweileh, Hanadi M Abu-Hadeed, Samah W Al-Jabi, Sa’ed H Zyoud

Published in: BMC Public Health | Issue 1/2014

Login to get access

Abstract

Background

Diabetes mellitus is a common chronic metabolic disorder and one of the main causes of death in Palestine. Palestinians are continuously living under stressful economic and military conditions which make them psychologically vulnerable. The purpose of this study was to investigate the prevalence of depression among type II diabetic patients and to examine the relationship between depression and socio-demographic factors, clinical factors, and glycemic control.

Methods

This was a cross-sectional study at Al-Makhfiah primary healthcare center, Nablus, Palestine. Two hundred and ninety-four patients were surveyed for the presence of depressive symptoms using Beck Depression Inventory (BDI-II) scale. Patients' records were reviewed to obtain data pertaining to age, sex, marital status, Body Mass Index (BMI), level of education, smoking status, duration of diabetes mellitus, glycemic control using HbA1C test, use of insulin, and presence of additional illnesses. Patients’ medication adherence was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8).

Results

One hundred and sixty four patients (55.8%) of the total sample were females and 216 (73.5%) were < 65 years old. One hundred and twenty patients (40.2%) scored ≥ 16 on BDI-II scale. Statistical significant association was found between high BDI-II score (≥ 16) and female gender, low educational level, having no current job, having multiple additional illnesses, low medication adherence and obesity (BMI ≥ 30 kg/m2). No significant association between BDI score and glycemic control, duration of diabetes, and other socio-demographic factors was found. Multivatriate analysis showed that low educational level, having no current job, having multiple additional illnesses and low medication adherence were significantly associated with high BDI-II scores.

Conclusion

Prevalence of depression found in our study was higher than that reported in other countries. Although 40% of the screened patients were potential cases of depression, none were being treated with anti-depressants. Psychosocial assessment should be part of routine clinical evaluation of these patients at primary healthcare clinics to improve quality of life and decrease adverse outcomes among diabetic patients.
Literature
1.
Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010, 87 (1): 4-14. 10.1016/j.diabres.2009.10.007.CrossRefPubMed
2.
Abdul-Rahim HF, Husseini A, Giacaman R, Jervell J, Bjertness E: Diabetes mellitus in an urban Palestinian population: prevalence and associated factors. East Mediterr Health J. 2001, 7 (1–2): 67-78.PubMed
3.
Husseini A, Abdul-Rahim H, Awartani F, Jervell J, Bjertness E: Prevalence of diabetes mellitus and impaired glucose tolerance in a rural Palestinian population. East Mediterr Health J. 2000, 6 (5–6): 1039-1045.PubMed
4.
Husseini A, Abdul-Rahim H, Awartani F, Giacaman R, Jervell J, Bjertness E: Type 2 diabetes mellitus, impaired glucose tolerance and associated factors in a rural Palestinian village. Diabet Med. 2000, 17 (10): 746-748. 10.1046/j.1464-5491.2000.00355.x.CrossRefPubMed
5.
Husseini A, Abu-Rmeileh NM, Mikki N, Ramahi TM, Ghosh HA, Barghuthi N, Khalili M, Bjertness E, Holmboe-Ottesen G, Jervell J: Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory. Lancet. 2009, 373 (9668): 1041-1049. 10.1016/S0140-6736(09)60109-4.CrossRefPubMed
6.
Greden JF: Physical symptoms of depression: unmet needs. J Clin Psychiatry. 2003, 64 (Suppl 7): 5-11.PubMed
7.
Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P, et al: Prevalence, severity, and unmet need for treatment of mental disorders in the world health organization world mental health surveys. JAMA. 2004, 291 (21): 2581-2590.CrossRefPubMed
8.
Meyer C: Depressive disorders were the fourth leading cause of global disease burden in the year 2000. Evid Based Ment Health. 2004, 7 (4): 123-10.1136/ebmh.7.4.123.CrossRefPubMed
9.
Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ: Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004, 184: 386-392. 10.1192/bjp.184.5.386.CrossRefPubMed
10.
Michaud CM, Murray CJ, Bloom BR: Burden of disease–implications for future research. JAMA. 2001, 285 (5): 535-539. 10.1001/jama.285.5.535.CrossRefPubMed
11.
Li C, Ford ES, Strine TW, Mokdad AH: Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care. 2008, 31 (1): 105-107.CrossRefPubMed
12.
Ali S, Stone MA, Peters JL, Davies MJ, Khunti K: The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006, 23 (11): 1165-1173. 10.1111/j.1464-5491.2006.01943.x.CrossRefPubMed
13.
Katon W, Von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, Ludman E, Walker E, Bush T, Young B: Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care. 2004, 27 (4): 914-920. 10.2337/diacare.27.4.914.CrossRefPubMed
14.
Katon WJ, Simon G, Russo J, Von Korff M, Lin EHB, Ludman E, Ciechanowski P, Bush T: Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care. 2004, 42 (12): 1222-1229. 10.1097/00005650-200412000-00009.CrossRefPubMed
15.
Giacaman R, Khatib R, Shabaneh L, Ramlawi A, Sabri B, Sabatinelli G, Khawaja M, Laurance T: Health status and health services in the occupied Palestinian territory. Lancet. 2009, 373 (9666): 837-849. 10.1016/S0140-6736(09)60107-0.CrossRef
16.
17.
Al-Amer RM, Sobeh MM, Zayed AA, Al-Domi HA: Depression among adults with diabetes in Jordan: risk factors and relationship to blood sugar control. J Diabetes Complications. 2011, 25 (4): 247-252. 10.1016/j.jdiacomp.2011.03.001.CrossRefPubMed
18.
Beck AT, Steer RA, Brown GK: Manual for Beck Depression lnventory-II. 1996, San Antonio, TX: Psychological Corporation
19.
Beck AT, Guth D, Steer RA, Ball R: Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther. 1997, 35 (8): 785-791. 10.1016/S0005-7967(97)00025-9.CrossRefPubMed
20.
Steer RA, Ball R, Ranieri WF, Beck AT: Further evidence for the construct validity of the Beck depression Inventory-II with psychiatric outpatients. Psychol Rep. 1997, 80 (2): 443-446. 10.2466/pr0.1997.80.2.443.CrossRefPubMed
21.
Steer RA, Ball R, Ranieri WF, Beck AT: Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients. J Clin Psychol. 1999, 55 (1): 117-128. 10.1002/(SICI)1097-4679(199901)55:1<117::AID-JCLP12>3.0.CO;2-A.CrossRefPubMed
22.
Steer RA, Cavalieri TA, Leonard DM, Beck AT: Use of the Beck Depression Inventory for Primary Care to screen for major depression disorders. Gen Hosp Psychiatry. 1999, 21 (2): 106-111. 10.1016/S0163-8343(98)00070-X.CrossRefPubMed
23.
Steer RA, Clark DA, Beck AT, Ranieri WF: Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA. Behav Res Ther. 1999, 37 (2): 183-190. 10.1016/S0005-7967(98)00087-4.CrossRefPubMed
24.
Steer RA, Rissmiller DJ, Beck AT: Use of the beck depression inventory-II with depressed geriatric inpatients. Behav Res Ther. 2000, 38 (3): 311-318. 10.1016/S0005-7967(99)00068-6.CrossRefPubMed
25.
Winter LB, Steer RA, Jones-Hicks L, Beck AT: Screening for major depression disorders in adolescent medical outpatients with the beck depression inventory for primary care. J Adolesc Health. 1999, 24 (6): 389-394. 10.1016/S1054-139X(98)00135-9.CrossRefPubMed
26.
Alansari BM: Beck Depression Inventory (BDI-II) items characteristics among undergraduate students of nineteen Islamic countries. Soc Behav Pers. 2005, 33 (7): 675-684. 10.2224/sbp.2005.33.7.675.CrossRef
27.
Alansari BM: Gender differences in depression among undergraduates from seventeen Islamic countries. Soc Behav Person. 2006, 34 (6): 729-738. 10.2224/sbp.2006.34.6.729.CrossRef
28.
Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE: Screening for depression in diabetes using the beck depression inventory. Psychosom Med. 1997, 59 (1): 24-31.CrossRefPubMed
29.
American Diabetes Association: Standards of medical care in diabetes--2010. Diabetes Care. 2010, 33 Suppl 1: S11-61.CrossRef
30.
Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986, 24 (1): 67-74. 10.1097/00005650-198601000-00007.CrossRefPubMed
31.
Jamous RM, Sweileh WM, Abu-Taha AS, Sawalha AF, Zyoud SH, Morisky DE: Adherence and satisfaction with oral hypoglycemic medications: a pilot study in Palestine. Int J Clin Pharm. 2011, 33 (6): 942-948. 10.1007/s11096-011-9561-7.CrossRefPubMed
32.
Pibernik-Okanovic M, Peros K, Szabo S, Begic D, Metelko Z: Depression in Croatian Type 2 diabetic patients: prevalence and risk factors. A Croatian survey from the European Depression in Diabetes (EDID) Research Consortium. Diabet Med. 2005, 22 (7): 942-945. 10.1111/j.1464-5491.2005.01528.x.CrossRefPubMed
33.
Chou KL, Chi I: Prevalence of depression among elderly Chinese with diabetes. Int J Geriatr Psychiatry. 2005, 20 (6): 570-575. 10.1002/gps.1328.CrossRefPubMed
34.
Ali S, Davies MJ, Taub NA, Stone MA, Khunti K: Prevalence of diagnosed depression in South Asian and white European people with type 1 and type 2 diabetes mellitus in a UK secondary care population. Postgrad Med J. 2009, 85 (1003): 238-243. 10.1136/pgmj.2008.074641.CrossRefPubMed
35.
Asghar S, Hussain A, Ali SM, Khan AK, Magnusson A: Prevalence of depression and diabetes: a population-based study from rural Bangladesh. Diabet Med. 2007, 24 (8): 872-877. 10.1111/j.1464-5491.2007.02136.x.CrossRefPubMed
36.
Pouwer F, Geelhoed-Duijvestijn PH, Tack CJ, Bazelmans E, Beekman AJ, Heine RJ, Snoek FJ: Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands. Diabet Med. 2010, 27 (2): 217-224. 10.1111/j.1464-5491.2009.02903.x.CrossRefPubMed
37.
Engum A, Mykletun A, Midthjell K, Holen A, Dahl AA: Depression and diabetes: a large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care. 2005, 28 (8): 1904-1909. 10.2337/diacare.28.8.1904.CrossRefPubMed
38.
Mezuk B, Eaton WW, Albrecht S, Golden SH: Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008, 31 (12): 2383-2390. 10.2337/dc08-0985.CrossRefPubMedPubMedCentral
39.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001, 24 (6): 1069-1078. 10.2337/diacare.24.6.1069.CrossRefPubMed
40.
Zahid N, Asghar S, Claussen B, Hussain A: Depression and diabetes in a rural community in Pakistan. Diabetes Res Clin Pract. 2008, 79 (1): 124-127. 10.1016/j.diabres.2007.07.006.CrossRefPubMed
41.
Lloyd CE, Dyer PH, Barnett AH: Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med. 2000, 17 (3): 198-202. 10.1046/j.1464-5491.2000.00260.x.CrossRefPubMed
42.
Bailey BJ: Mediators of depression in adults with diabetes. Clin Nurs Res. 1996, 5 (1): 28-42. 10.1177/105477389600500104.CrossRefPubMed
43.
Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL: Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry. 1987, 44 (4): 328-336. 10.1001/archpsyc.1987.01800160032006.CrossRefPubMed
44.
Grisel JE, Rasmussen PR, Sperry L: Anxiety and depression: physiological and pharmacological considerations. J Individ Psychol. 2006, 62 (4): 398-416.
45.
Lustman PJ, Clouse RE: Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications. 2005, 19 (2): 113-122.PubMed
46.
47.
Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000, 160 (21): 3278-3285. 10.1001/archinte.160.21.3278.CrossRefPubMed
48.
Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, Kinder L, Young B, Von Korff M: The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005, 28 (11): 2668-2672. 10.2337/diacare.28.11.2668.CrossRefPubMed
49.
Sahota PKC, Knowler WC, Looker HC: Depression, diabetes, and glycemic control in an American Indian community. J Clin Psychiatry. 2008, 69 (5): 800-809. 10.4088/JCP.v69n0513.CrossRefPubMedPubMedCentral
50.
Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000, 23 (7): 934-942. 10.2337/diacare.23.7.934.CrossRefPubMed
51.
Wagner JA, Abbott GL, Heapy A, Yong L: Depressive symptoms and diabetes control in African Americans. J Immigr Minor Health. 2009, 11 (1): 66-70. 10.1007/s10903-008-9147-1.CrossRefPubMed
52.
Dirmaier J, Watzke B, Koch U, Schulz H, Lehnert H, Pieper L, Wittchen HU: Diabetes in primary care: prospective associations between depression, nonadherence and glycemic control. Psychother Psychosom. 2010, 79 (3): 172-178. 10.1159/000296135.CrossRefPubMed
53.
De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ: Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001, 63 (4): 619-630.CrossRefPubMed
54.
Egede LE: Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes. Psychosom Med. 2005, 67 (1): 46-51. 10.1097/01.psy.0000149260.82006.fb.CrossRefPubMed
55.
Black SA, Markides KS, Ray LA: Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care. 2003, 26 (10): 2822-2828. 10.2337/diacare.26.10.2822.CrossRefPubMed
56.
Winocour PH, Main CJ, Medlicott G, Anderson DC: A psychometric evaluation of adult patients with type 1 (insulin-dependent) diabetes mellitus: prevalence of psychological dysfunction and relationship to demographic variables, metabolic control and complications. Diabetes Res. 1990, 14 (4): 171-176.PubMed
57.
Viinamaki H, Niskanen L, Uusitupa M: Mental well-being in people with non-insulin-dependent diabetes. Acta Psychiatr Scand. 1995, 92 (5): 392-397. 10.1111/j.1600-0447.1995.tb09602.x.CrossRefPubMed
58.
Peyrot M, Rubin RR: Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care. 1997, 20 (4): 585-590. 10.2337/diacare.20.4.585.CrossRefPubMed
59.
Surwit RS, van Tilburg MA, Parekh PI, Lane JD, Feinglos MN: Treatment regimen determines the relationship between depression and glycemic control. Diabetes Res Clin Pract. 2005, 69 (1): 78-80. 10.1016/j.diabres.2004.11.002.CrossRefPubMed
60.
Van Tilburg MA, McCaskill CC, Lane JD, Edwards CL, Bethel A, Feinglos MN, Surwit RS: Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med. 2001, 63 (4): 551-555.CrossRefPubMed
61.
Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB: The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003, 25 (4): 246-252. 10.1016/S0163-8343(03)00055-0.CrossRefPubMed
62.
de Groot M, Jacobson AM, Samson JA, Welch G: Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res. 1999, 46 (5): 425-435. 10.1016/S0022-3999(99)00014-8.CrossRefPubMed
63.
Georgiades A, Zucker N, Friedman KE, Mosunic CJ, Applegate K, Lane JD, Feinglos MN, Surwit RS: Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med. 2007, 69 (3): 235-241. 10.1097/PSY.0b013e318042588d.CrossRefPubMed
64.
de Groot M, Doyle T, Hockman E, Wheeler C, Pinkerman B, Shubrook J, Gotfried R, Schwartz F: Depression among type 2 diabetes rural Appalachian clinic attendees. Diabetes Care. 2007, 30 (6): 1602-1604. 10.2337/dc06-1599.CrossRefPubMedPubMedCentral
65.
de Groot M, Pinkerman B, Wagner J, Hockman E: Depression treatment and satisfaction in a multicultural sample of type 1 and type 2 diabetic patients. Diabetes Care. 2006, 29 (3): 549-553. 10.2337/diacare.29.03.06.dc05-1396.CrossRefPubMed
66.
Nichols GA, Brown JB: Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care. 2003, 26 (3): 744-749. 10.2337/diacare.26.3.744.CrossRefPubMed
67.
Sacco WP, Wells KJ, Friedman A, Matthew R, Perez S, Vaughan CA: Adherence, body mass index, and depression in adults with type 2 diabetes: the mediational role of diabetes symptoms and self-efficacy. Health Psychol. 2007, 26 (6): 693-700.CrossRefPubMed
68.
Lerman I, Lozano L, Villa AR, Hernandez-Jimenez S, Weinger K, Caballero AE, Salinas CA, Velasco ML, Gomez-Perez FJ, Rull JA: Psychosocial factors associated with poor diabetes self-care management in a specialized center in Mexico City. Biomed Pharmacother. 2004, 58 (10): 566-570. 10.1016/j.biopha.2004.09.003.CrossRefPubMed
69.
Park H, Hong Y, Lee H, Ha E, Sung Y: Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. J Clin Epidemiol. 2004, 57 (9): 978-984. 10.1016/j.jclinepi.2004.01.015.CrossRefPubMed
70.
Finkelstein EA, Bray JW, Chen H, Larson MJ, Miller K, Tompkins C, Keme A, Manderscheid R: Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care. 2003, 26 (2): 415-420. 10.2337/diacare.26.2.415.CrossRefPubMed
71.
McCollum M, Ellis SL, Regensteiner JG, Zhang W, Sullivan PW: Minor depression and health status among US adults with diabetes mellitus. Am J Manag Care. 2007, 13 (2): 65-72.PubMed
72.
Brown GC, Brown MM, Sharma S, Brown H, Gozum M, Denton P: Quality of life associated with diabetes mellitus in an adult population. J Diabetes Complications. 2000, 14 (1): 18-24. 10.1016/S1056-8727(00)00061-1.CrossRefPubMed
73.
Egede LE: Diabetes, major depression, and functional disability among US adults. Diabetes Care. 2004, 27 (2): 421-428. 10.2337/diacare.27.2.421.CrossRefPubMed
74.
Egede LE: Effect of depression on self-management behaviors and health outcomes in adults with type 2 diabetes. Curr Diabetes Rev. 2005, 1 (3): 235-243. 10.2174/157339905774574356.CrossRefPubMed
75.
Gonzalez JS, Safren SA, Delahanty LM, Cagliero E, Wexler DJ, Meigs JB, Grant RW: Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabet Med. 2008, 25 (9): 1102-1107. 10.1111/j.1464-5491.2008.02535.x.CrossRefPubMedPubMedCentral
76.
Blazer DG, Moody-Ayers S, Craft-Morgan J, Burchett B: Depression in diabetes and obesity: racial/ethnic/gender issues in older adults. J Psychosom Res. 2002, 53 (4): 913-916. 10.1016/S0022-3999(02)00314-8.CrossRefPubMed
77.
Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS: Clinical inertia. Ann Intern Med. 2001, 135 (9): 825-834. 10.7326/0003-4819-135-9-200111060-00012.CrossRefPubMed
78.
Karlson B, Agardh CD: Burden of illness, metabolic control, and complications in relation to depressive symptoms in IDDM patients. Diabet Med. 1997, 14 (12): 1066-1072. 10.1002/(SICI)1096-9136(199712)14:12<1066::AID-DIA462>3.0.CO;2-M.CrossRefPubMed
79.
Miyaoka Y, Miyaoka H, Motomiya T, Kitamura S, Asai M: Impact of sociodemographic and diabetes-related characteristics on depressive state among non-insulin-dependent diabetic patients. Psychiatry Clin Neurosci. 1997, 51 (4): 203-206. 10.1111/j.1440-1819.1997.tb02583.x.CrossRefPubMed
80.
Palinkas LA, Barrett-Connor E, Wingard DL: Type 2 diabetes and depressive symptoms in older adults: a population-based study. Diabet Med. 1991, 8 (6): 532-539. 10.1111/j.1464-5491.1991.tb01646.x.CrossRefPubMed
81.
Tsai L-Y, Tsai S-M, Lin M-N, Liu S-F: Effect of hemoglobin variants (Hb J, Hb G, and Hb E) on HbA1c values as measured by cation-exchange HPLC (Diamat). Clin Chem. 2001, 47 (4): 756-758.PubMed
82.
Nasir NM, Thevarajah M, Yean CY: Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements. Int J Diabetes Dev Ctries. 2010, 30 (2): 86-90. 10.4103/0973-3930.62598.CrossRefPubMedPubMedCentral
Metadata
Title
Prevalence of depression among people with type 2 diabetes mellitus: a cross sectional study in Palestine
Authors
Waleed M Sweileh
Hanadi M Abu-Hadeed
Samah W Al-Jabi
Sa’ed H Zyoud
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2014
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-14-163

Other articles of this Issue 1/2014

BMC Public Health 1/2014 Go to the issue

Research article

Tools to support evidence-informed public health decision making

Research article

Working and hypertension: gaps in employment not associated with increased risk in 13 European countries, a retrospective cohort study

Research article

Changes in colorectal cancer screening intention among people aged 18–49 in the United States

Research article

Perceptions of consent, permission structures and approaches to the community: a rapid ethical assessment performed in North West Cameroon

Study protocol

Efficacy of family mediation and the role of family violence: study protocol

Study protocol

I Move: systematic development of a web-based computer tailored physical activity intervention, based on motivational interviewing and self-determination theory